40.065.59% ( -2.37 )
Delay Closed: Nov 18, 15:00:00Valuation
Current ValuationThe current P/E ratio is 44.78, within the reasonable range, cheaper than 33.29% of the time in the past 3 years, and the industry ranks 97/222, the industry Median 21.64.
44.78xP/E
¥42.43Stock price
¥0.95Earnings per share
44.78xP/E
Stock price¥42.43Earnings per share¥0.95
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 41.21x
- Typical range
- 32.23x–47.79x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.64x
015304560
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.64x
0x40x80x120x160x200x
| Name/Symbol | |||
|---|---|---|---|
600436SHZZPZH | 59.96x | 17.36% | ¥78.96B |
002653SZHaisco | 47.26x | 572.55% | ¥61.61B |
002821SZAsymchem | 44.84x | 16.47% | ¥53.11B |
300765SZCSPC Innovation | 45.59x | 628.47% | ¥45.26B |
002294SZSalubris | 41.58x | 29.31% | ¥29.73B |
300199SZHYBIO | 48.79x | -- | ¥19.61B |
603858SHBUCHANG PHARMA | 55.34x | -- | ¥15.60B |
301569SZNOVAST | 47.93x | -- | ¥14.92B |
002626SZKingdomway | 43.19x | 26.67% | ¥10.06B |
300725SZPHARMABLOCK | 44.78x | 18.18% | ¥9.92B |
600851SHHX GROUP | 50.37x | -- | ¥9.62B |
600789SHLKPC | 52.15x | -- | ¥7.11B |
603538SHMenovo | 58.92x | -- | ¥6.51B |
688553SHHUIYU PHARMACEUTICAL | 49.04x | -- | ¥6.33B |
002390SZxinbang phar. | 41.44x | -- | ¥5.73B |
688799SHHWPC | 49.82x | 24.46% | ¥5.68B |
301393SZHighfine | 45.53x | -- | ¥5.62B |
002907SZPharscin Pharma | 55.59x | -- | ¥5.22B |
002940SZALK | 40.47x | -- | ¥4.47B |
301281SZKeyuan Pharma | 52.70x | -- | ¥3.71B |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
